GRM1 and breast carcinoma: GRM1 signaling has been implicated in multiple malignant cancers including colon adenocarcinoma, melanoma, lung carcinoma, thyroid carcinoma, breast carcinoma, astrocytoma, neuroblastoma and rabdomyosarcoma [4], [5], [24].